STAT3 Inhibitor WP1066
NU 21C06
Phase 2 small_molecule active
Quick answer
STAT3 Inhibitor WP1066 for Glioblastoma, IDH-Wildtype is a Phase 2 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moleculin Biotech
- Indication
- Glioblastoma, IDH-Wildtype
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active